Delivery Order SPE2DB22D3501-SPE2DB24FUZ20
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,802.75 fixed-price delivery order is for 4,567,465,230 units of Timolol Maleate 0.25% eye drops, which are a treatment for glaucoma. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol Maleate 0.5% eye drops in unit dose packaging. The $1,403.68 Firm Fixed Price delivery order contract has an ultimate completion date of April 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.28 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used for the treatment of eye conditions. The contract has a period of performance through January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB24FA0R3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,074.80 firm fixed-price delivery order is for Timolol Maleate 0.5% eye drops, with an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,393.48, is for the delivery of Timolol Maleate 0.5% eye drops in 60-count units. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of November 15, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol Maleate 0.5% eye drops in unit dose 60s packaging. The firm-fixed-price delivery order, valued at $1,173.52, has an ultimate completion date of January 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,617.93, is for the delivery of Timolol 0.25% Gel-Solution 5ML, a prescription eye drop medication. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Timolol 0.5% gel-solution in 5ml quantities. The award, valued at $8,263.10, has a completion date of February 23, 2024. Amerisourcebergen Drug Corp has received numerous similar awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and...
- This federal contract award is for the delivery of Timolol Maleate 0.5% eye drops to the Defense Logistics Agency (DLA). The $1,013.70 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 1, 2022. The contract has a completion date of March 2, 2022 and was not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is the prime contractor on this award. Cencora, Inc....
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,822.10 firm fixed price contract is for the supply of Timolol 0.5% eye drops, a common prescription medication. Amerisourcebergen delivers a wide range of pharmaceutical products and medical supplies to various federal agencies, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA)...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUZ20Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,689.20 firm fixed price delivery order is for the supply of Timolol Maleate 0.5% eye drops in 10ml containers, with a performance period through March 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order is issued under that IDC. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/19/24 |